Clinical Trials Logo
  1. Home
  2. Postmenopausal Disorder
  3. NCT06015919
  4. Details
NCT06015919 Clinical Trial

Effect of Dash Diet and Acupuncture on Hypertention in Postmenopausal Women

Postmenopausal Disorder Clinical Trial

Official title:
Effect of Dash Diet and Acupuncture on Hypertention in Postmenopausal Women

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT06015919
Other study ID # P.T.REC/012/003872
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 5, 2022
Est. completion date August 20, 2023

Study information
Verified date August 2023
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A study of effect of dash diet and acupuncture on hypertension in postmenopausal women

Description:

45 of post menopausal women divided into three groups A,B,C - Group (A): It will include 15 post-menopausal women who will be treated by DASH diet and anti-hypertensive drugs. - Group (B): It will include 15 post-menopausal women who will be treated by acupuncture and anti-hypertensive drugs. - Group (C): It will include 15 post-menopausal women who will be treated by DASH diet, acupuncture and anti-hypertensive drugs.

Recruitment information / eligibility
Status Completed
Enrollment 45
Est. completion date August 20, 2023
Est. primary completion date April 25, 2023
Accepts healthy volunteers No
Gender Female
Age group 50 Years to 60 Years
Eligibility Inclusion Criteria: - Their body mass index will be ranged from 25 -29.9 kg/m2 - All patients will be medically stable when attending the study. - The DASH eating plan of 1800 kcal per day will be used in the study. Exclusion Criteria: - Auditory and visual problems. - Chronic renal failure. - Myocardial infarction or arrythmias with heart failure.

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• dash diet
Group (A): It will include 15 post-menopausal women who will be treated by DASH diet and anti-hypertensive drugs. Group (B): It will include 15 post-menopausal women who will be treated by acupuncture and anti-hypertensive drugs. Group (C): It will include 15 post-menopausal women who will be treated by DASH diet, acupuncture and anti-hypertensive drugs.
Device:
• Acupuncture
acupuncture

Locations
Country Name City State
Egypt Alaa Nabil Elsayed Mohamed Abu hammad Elsharqia

Sponsors (2)
Lead Sponsor Collaborator
Cairo University faculty of physical therapy

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Other assessment of quality of life it will be measured by sf 36 questionnaire pre and post treatment 3 months
Primary blood pressure it will be measured by sphygmomanometer pre and post treatment 3 months
Secondary sodium and potassium levels it will be measured by blood analysis pre and post treatment 3 months
See also
  Status Clinical Trial Phase
Completed NCT01745042 - Anthropometric, Metabolic, Cardiovascular and Symptomatic Profile in Postmenopausal Women N/A
Completed NCT01398605 - Physical Activity in Postmenopausal Women N/A
Not yet recruiting NCT03672760 - Inspiratory Muscle Training X CardioBreath App Effects On Vagal Modulation And Pulse Wave Velocity N/A
Completed NCT01833663 - Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women Phase 4
Recruiting NCT06303297 - Effects of Reflexology and Generalized Stretching in Postmenopausal Females. N/A
Recruiting NCT04807894 - Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo Phase 4
Completed NCT04255992 - Short Term Cardiovascular Effects and Oxidative Status of Calcium and Vitamin D Supplementation of Postmenopausal Hypertensive Blacks Women Phase 4
Completed NCT03280693 - Relationships Among Body Mass Index, Body Balance and Bone Mineral Density in Postmenopausal Women N/A
Completed NCT01519583 - WalkMore Walking Interventions for Overweight/Obese Postmenopausal Women N/A
Recruiting NCT05031702 - Camelia Sinensis for Basal Metabolism and Body Composition N/A
Completed NCT03295487 - ToT and Estrogen in Postmenopausal Females Phase 2/Phase 3
Completed NCT05464654 - Vaginal Biorevitalization With Polydeoxyribonucleotides for the Improvement of the Genitourinary Syndrome of Menopause N/A
Completed NCT01400724 - Inofolic NRT and the Metabolic Syndrome N/A
Completed NCT06079528 - Effect of Electromagnetic Stimulation Combined With Visceral Manipulation on Stress Urinary Incontinence In Postmenopausal Women N/A
Active, not recruiting NCT00926315 - Gene Expression Profile of Breast Cancer Samples After Vitamin D Supplementation N/A
Active, not recruiting NCT03469518 - Effect of β-cryptoxanthin (β-Cx), Plant Sterols and Galactooligosaccharides on Systemic and Gastrointestinal Markers N/A
Completed NCT04701463 - A Specialized Amino Acid Mixture on Body Composition and Skin State in Overweight and Obese Class I Postmenopausal Women N/A
Completed NCT01074723 - B-cryptoxanthin and Phytosterols on Bone Remodeling and Cardiovascular Risk Factors Phase 1
Completed NCT04492540 - Response of Sex Hormones and Different Functions to Exercise and Diet in Elderly Women N/A
Completed NCT03233932 - CKD-841 Pharmacokinetic/Pharmacodynamic Study Phase 1